Phase II study of the combination of gemcitabine and nedaplatin for advanced non-small-cell lung cancer. [electronic resource]
Producer: 20060921Description: 181-7 p. digitalISSN:- 0169-5002
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Deoxycytidine -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Humans
- Immunosuppressive Agents -- administration & dosage
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Staging
- Organoplatinum Compounds -- administration & dosage
- Retrospective Studies
- Ribonucleotide Reductases -- antagonists & inhibitors
- Survival Rate
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.